Obesity and Gastrointestinal Hormones-Dual Effect of Angiotensin II Receptor Blockade and a Partial Agonist of PPAR-&ggr;

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|9|2|162-166

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.9, Iss.2, 2011-03, pp. : 162-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR&ggr; Agonists: Beneficial Effect on Blood Pressure Beyond Glycemic Control?

By  

Current Hypertension Reviews, Vol. 2, Iss. 1, 2006-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Thiazolidinediones as PPAR&ggr; Ligands with the Potential for the Prevention of Cardiovascular Disease in Diabetes

By  

Current Diabetes Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 227-239

Bentham Science Publishers

Access to resources Recommend Favorite

Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers

By  

Cerebrovascular Diseases, Vol. 26, Iss. 2, 2008-06 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation

By Isobe Aki   Takeda Takashi   Sakata Masahiro   Miyake Asako   Yamamoto Toshiya   Minekawa Ryoko   Nishimoto Fumihito   Oskamoto Yoko   Walker Cheryl Lyn   Kimura Tadashi  

Human Reproduction, Vol. 23, Iss. 2, 2008-02 ,pp. : 440-446

Oxford University Press

Access to resources Recommend Favorite

Angiotensin II Type 1 Receptor Blockade: a Novel Therapeutic Concept

By JOHNSTON COLIN I.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 9-13

Informa Healthcare

Access to resources Recommend Favorite